Literature DB >> 10498912

p38 MAPK signalling cascades in inflammatory disease.

E Herlaar1, Z Brown.   

Abstract

Inflammatory mediators released during acute and chronic diseases activate multiple intracellular signalling cascades including the mitogen-activated protein kinase (MAPK) signal transduction pathway, which plays a significant role in the recruitment of leukocytes to sites of inflammation. Stimulation of leukocytes by pro-inflammatory cytokines is known to result in the activation of the MAPK isoform p38. However, the functional consequences of p38 MAPK activation during leukocyte recruitment, including adhesion, migration and effector functions such as oxidative burst and degranulation, are only just beginning to be elucidated. Specific p38 inhibitors aimed at reducing the production of inflammatory mediators are now being developed, and might in the future provide more effective treatment for inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498912     DOI: 10.1016/s1357-4310(99)01544-0

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  118 in total

1.  Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases.

Authors:  A G Papavassiliou
Journal:  EMBO Rep       Date:  2001-02       Impact factor: 8.807

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response.

Authors:  Hong-Lin Su; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Inhibition of stromal cell-derived factor-1α/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas.

Authors:  Keisuke Omori; Nanae Nagata; Kaori Kurata; Yoko Fukushima; Erika Sekihachi; Nobutaka Fujii; Tomoko Namba-Hamano; Yoshitsugu Takabatake; Marcus Fruttiger; Takashi Nagasawa; Akiyoshi Uemura; Takahisa Murata
Journal:  JCI Insight       Date:  2018-12-06

5.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

6.  Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages.

Authors:  Veselina Korcheva; John Wong; Meghan Lindauer; David B Jacoby; Mihail S Iordanov; Bruce Magun
Journal:  Mol Immunol       Date:  2007-01-25       Impact factor: 4.407

7.  Deletion of the Fractalkine Receptor, CX3CR1, Improves Endogenous Repair, Axon Sprouting, and Synaptogenesis after Spinal Cord Injury in Mice.

Authors:  Camila M Freria; Jodie C E Hall; Ping Wei; Zhen Guan; Dana M McTigue; Phillip G Popovich
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

8.  Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome.

Authors:  Maria Wilczynska; Samuel Rice; Gareth Davies; Keir E Lewis
Journal:  Sleep Breath       Date:  2013-12-11       Impact factor: 2.816

9.  Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Authors:  A R Khaled; A N Moor; A Li; K Kim; D K Ferris; K Muegge; R J Fisher; L Fliegel; S K Durum
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Authors:  Awatef Ben Jemaa; Sataa Sallami; Dunia Ramarli; Marco Colombatti; Ridha Oueslati
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.